Trade

with

Ironwood Pharmaceuticals Inc
(NASDAQ: IRWD)
AdChoices
12.94
+0.43
+3.44%
After Hours :
-
-
-

Open

12.99

Previous Close

12.51

Volume (Avg)

39.05k (1.25M)

Day's Range

12.71-12.99

52Wk Range

8.95-15.95

Market Cap.

1.74B

Dividend Rate ( Yield )

-

Beta

1.51

Shares Outstanding

120.87M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 22.88M

    • Net Income

    • -272.81M

    • Market Cap.

    • 1.74B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -712.38

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.51

    • Forward P/E

    • -22.68

    • Price/Sales

    • 50.76

    • Price/Book Value

    • 12.29

    • Price/Cash flow

    • -8.57

      • EBITDA

      • -240.08M

      • Return on Capital %

      • -59.26

      • Return on Equity %

      • -159.11

      • Return on Assets %

      • -59.26

      • Book Value/Share

      • 1.02

      • Shares Outstanding

      • 120.87M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 12.00

        • Credit Rating

        • -

        • Analysts

        • 4

        • EPS Estimate

        • -0.52

        • Cashflow Estimate

        • -0.72

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -29.20

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • -

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 0.59

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 52.25

            • 64.72

            • Pre-Tax Margin

            • -712.38

            • 13.77

            • Net Profit Margin

            • -712.38

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 93.60

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -335.70

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • -331.40

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 1.21

              • 0.33

              • Current Ratio

              • 7.83

              • 1.52

              • Quick Ratio

              • 7.36

              • 0.87

              • Interest Coverage

              • -9.58

              • 6.77

              • Leverage Ratio

              • 2.62

              • 1.91

              • Book Value/Share

              • 1.02

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -7.43

                • 63.69

                • P/E Ratio 5-Year High

                • -11.21

                • 237.47

                • P/E Ratio 5-Year Low

                • -5.07

                • 19.71

                • Price/Sales Ratio

                • 52.91

                • 3.64

                • Price/Book Value

                • 12.82

                • 3.39

                • Price/Cash Flow Ratio

                • -8.57

                • 21.79

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -159.11

                    (-)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • -59.26

                    (-47.10)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • -63.78

                    (-)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • -

                  • 27.79k

                  • Inventory Turnover

                  • 0.90

                  • 1.80

                  • Asset Turnover

                  • 0.08

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -252.00M
                  Operating Margin
                  -1,101.36
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -8.57
                  Ownership

                  Institutional Ownership

                  97.74%

                  Top 10 Institutions

                  68.23%

                  Mutual Fund Ownership

                  53.73%

                  Float

                  74.19%

                  5% / Insider Ownership

                  4.56%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity® Growth Company Fund

                  •  

                    6,775,620

                  • 0.00

                  • 4.86

                  • Fidelity® Select Biotechnology Portfolio

                  •  

                    4,692,810

                  • 0.00

                  • 3.37

                  • Vanguard Health Care Fund

                  •  

                    3,901,498

                  • 0.00

                  • 2.80

                  • Morgan Stanley Inst Mid Cap Growth Port

                  •  

                    3,539,459

                  • 0.00

                  • 2.54

                  • Fidelity® OTC Portfolio

                  •  

                    3,220,042

                  • 0.00

                  • 2.31

                  • Pictet-Biotech

                  •  

                    2,984,800

                  • 0.07

                  • 2.50

                  • Janus Triton Fund

                  •  

                    2,488,696

                  • 0.00

                  • 1.79

                  • Vanguard Small Cap Index

                  •  

                    2,099,396

                  • 0.79

                  • 1.51

                  • Vanguard Total Stock Mkt Idx

                  •  

                    1,942,131

                  • 0.00

                  • 1.39

                  • Eaton Vance Worldwide Health Sciences Fu

                  •  

                    1,900,000

                  • 8.57

                  • 1.36

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity Management and Research Company

                  •  

                    19,705,803

                  • 0.00%

                  • 14.16

                  • Wellington Management Company, LLP

                  •  

                    16,727,455

                  • +0.50%

                  • 12.02

                  • Bvf Inc

                  •  

                    9,208,909

                  • -1.01%

                  • 6.62

                  • Orbimed Advisors, LLC

                  •  

                    8,935,900

                  • +725.79%

                  • 6.42

                  • Morgan Stanley Investment Management Inc

                  •  

                    7,965,667

                  • -0.34%

                  • 5.73

                  • Vanguard Group, Inc.

                  •  

                    7,200,806

                  • +0.77%

                  • 5.18

                  • State Of Wisconsin Investment Board

                  •  

                    4,755,497

                  • -24.52%

                  • 3.42

                  • BlackRock Fund Advisors

                  •  

                    4,720,980

                  • -4.82%

                  • 3.39

                  • Millennium Management LLC

                  •  

                    3,367,745

                  • -36.56%

                  • 2.42

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Slow Growth

                  Style

                  Small Core

                  Ironwood Pharmaceuticals, Inc. was incorporated in Delaware on January 5, 1998. On April 7, 2008, the Company changed its name from Microbia, Inc. to Ironwood Pharmaceuticals, Inc. The Company is an entrepreneurial pharmaceutical company that discovers, develops and intends to commercialize differentiated medicines that improve patients' lives. The Company currently operates its human therapeutics business segment. Human therapeutics segment consists of the development and commercialization of its product candidates, including linaclotide. The Company is subject to federal, state, city and local laws and regulations governing the use, manufacture, storage, handling and disposal of these hazardous materials.

                  Key People

                  Peter M. Hecht,PhD

                  CEO/Director

                  Dr. Bryan E. Roberts,PhD

                  Chairman of the Board/Director

                  Joseph C. Cook,Jr

                  Co-Founder/Director

                  Mr. Thomas Graney

                  CFO/Senior VP, Divisional

                  Gina Consylman

                  Vice President/Controller/Chief Accounting Officer

                  • Ironwood Pharmaceuticals Inc

                  • 301 Binney Street

                  • Cambridge, MA 02142

                  • USA.Map

                  • Phone: +1 617 621-7722

                  • Fax: +1 617 494-0480

                  • ironwoodpharma.com

                  Incorporated

                  1998

                  Employees

                  534

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: